First Test Batches of Russia’s AI assisted Cancer Vaccine Have Been Created

Russian scientists have produced the first three test batches of a newly developed cancer vaccine at the Gamaleya Institute in Moscow. This new “vaccine” is said to be a breakthrough drug. It’s an artificial intelligence-assisted, mRNA-based vaccine designed to target malignant tumors using the patient’s own genetic data.

Russia’s Cancer “Vaccine” Will Rollout This Fall

The center’s director, Alexander Gintsburg, has said that hopefully, the scientists can use this personalized vaccine to train the human immune system to attack tumors in the body.

According to a report by RT, initial records on the readiness of the vaccine first emerged in September. Preclinical studies showed the drug could shrink tumors and slow their growth by 60-80%, depending on patient characteristics. The vaccine was initially expected to be used in patients with colorectal cancer.

“Most importantly, our leading oncology center – the Herzen Institute, headed by academician [Andrey] Kaprin – has obtained the full set of approvals needed to use the technology, from diagnostics and mRNA production to administering it to patients,” Gintsburg said. The vaccine batches remain experimental even though they have passed all quality checks, he said on Wednesday.

This vaccine is not designed to stop disease transmission, which is a good clarification, considering cancer cannot be transmitted from human to human. Instead, this cancer vaccine will act on the immune system and train it to recognize and destroy tumor cells.

This is a new class of vaccine, used to treat late-stage cancers.

The new vaccine is a personalized treatment built to target malignant tumors using the patient’s own genetic information. Developed with the help of artificial intelligence, the mRNA platform allows each dose to be tailored to an individual’s cancer profile, potentially offering a more precise and effective therapy. –RT

All mRNA Injections, Including Cancer Vaccines, May Accelerate the Development of Cancer

Something about this kind of technology being used for cancer treatment seems off-putting. Considering cancer cannot be transmitted, is the term vaccine even appropriate? Why not just call it gene therapy? It would secure those opposed to vaccinations quite a bit more if the labeling and intent were honest from the beginning. Do you agree? Why or why no?

This article has been contributed by SHTF Plan. Visit www.SHTFplan.com for alternative news, commentary and preparedness info.